Page last updated: 2024-08-21

vasicinone and Parkinson Disease

vasicinone has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, RL; Chung, LC; Day, CH; Ho, TJ; Huang, CY; Ju, DT; Kuo, WW; Liao, PH; Sivalingam, K; Viswanadha, VP	1

Other Studies

1 other study(ies) available for vasicinone and Parkinson Disease

Article	Year
Effect of Vasicinone against Paraquat-Induced MAPK/p53-Mediated Apoptosis via the IGF-1R/PI3K/AKT Pathway in a Parkinson's Disease-Associated SH-SY5Y Cell Model. Nutrients, 2019, Jul-19, Volume: 11, Issue:7 Topics: Alkaloids; Apoptosis; Cell Line; Cell Survival; Humans; In Situ Nick-End Labeling; MAP Kinase Signaling System; Neuroprotective Agents; Paraquat; Parkinson Disease; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptor, IGF Type 1; Signal Transduction; Tumor Suppressor Protein p53	2019

Article

Year

Effect of Vasicinone against Paraquat-Induced MAPK/p53-Mediated Apoptosis via the IGF-1R/PI3K/AKT Pathway in a Parkinson's Disease-Associated SH-SY5Y Cell Model.

Nutrients, 2019, Jul-19, Volume: 11, Issue:7

Topics: Alkaloids; Apoptosis; Cell Line; Cell Survival; Humans; In Situ Nick-End Labeling; MAP Kinase Signaling System; Neuroprotective Agents; Paraquat; Parkinson Disease; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptor, IGF Type 1; Signal Transduction; Tumor Suppressor Protein p53

2019